[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Opus Genetics Inc (IRD)

Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Opus Genetics Inc 8 Davis Drive Suite 220 Durham NC 27713 USA

https://opusgtx.com Employees: 28 P: 984-884-6030

Sector:

Medical

Description:

Opus Genetics Inc. is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc., formerly known as Ocuphire Pharma Inc., is based in Farmington Hills, Michigan.

Key Statistics

Overview:

Market Capitalization, $K 287,330
Enterprise Value, $K 242,240
Shares Outstanding, K 82,566
Float, K 72,906
% Float 88.30%
Short Interest, K 8,228
Short Float 9.97%
Days to Cover 5.25
Short Volume Ratio 0.60
% of Insider Shareholders 11.70%
% of Institutional Shareholders 14.97%

Financials:

Annual Sales, $ 14,200 K
Annual Net Income, $ -49,590 K
Last Quarter Sales, $ 2,160 K
Last Quarter Net Income, $ -65,540 K
EBIT, $ -43,030 K
EBITDA, $ -42,980 K

Growth:

1-Year Return 192.86%
3-Year Return -19.61%
5-Year Return -21.53%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 88.45%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.75 on 05/12/26
Next Earnings Date 08/12/26 [--]
Earnings Per Share ttm -1.13
EPS Growth vs. Prev Qtr -435.71%
EPS Growth vs. Prev Year -134.38%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 11/06/20

IRD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -191.21%
Profit Margin % -349.23%
Debt/Equity 0.00
Price/Sales 20.71
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.64
Interest Coverage -380.46
60-Month Beta 0.55
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.